Mónica Palma Anselmo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In an ongoing phase II study we are evaluating the role of alpha-2b recombinant interferon in Hodgkin's disease; the study design includes patients with high-risk parameters who are treated by combination chemotherapy MOPP, ABVD, MOPP + ABVD or equivalent combinations. At the end of the therapeutic program which could include also radiotherapy, patients(More)
  • 1